Literature DB >> 22214965

Assessment of invasion in lung adenocarcinoma classification, including adenocarcinoma in situ and minimally invasive adenocarcinoma.

Alain C Borczuk1.   

Abstract

Classification of adenocarcinoma has undergone recent evaluation to better align histological classification with clinical outcomes. One terminology, in particular, that of bronchioloalveolar carcinoma (BAC), has been debated for many decades. Although initial discussion surrounded the cell-of-origin of this tumor, more recent confusion has been generated from the use of this term both as a pattern of growth within an otherwise invasive adenocarcinoma and as a term for a pre-invasive tumor synonymous with adenocarcinoma in situ. As a result, adenocarcinomas with quite different radiology, gross morphology and metastatic potential have been associated with the BAC term. Focusing on invasion and using an illustrative case, we will explore the current recommendations that incorporate assessment of invasion to clarify the confusion caused by the different uses of the historical term 'BAC'.

Entities:  

Mesh:

Year:  2012        PMID: 22214965     DOI: 10.1038/modpathol.2011.151

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  8 in total

1.  Pure ground-glass nodules: are they really indolent?

Authors:  Julien G Cohen; Gilbert R Ferretti
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

2.  Low-depth whole genome sequencing reveals copy number variations associated with higher pathologic grading and more aggressive subtypes of lung non-mucinous adenocarcinoma.

Authors:  Zheng Wang; Lin Zhang; Lei He; Di Cui; Chenglong Liu; Liangyu Yin; Min Zhang; Lei Jiang; Yuyan Gong; Wang Wu; Bi Liu; Xiaoyu Li; David S Cram; Dongge Liu
Journal:  Chin J Cancer Res       Date:  2020-06       Impact factor: 5.087

3.  A comparison of ultra-high-resolution CT target scan versus conventional CT target reconstruction in the evaluation of ground-glass-nodule-like lung adenocarcinoma.

Authors:  Yanyan Zhu; Dailun Hou; Meihong Lan; Xiaoli Sun; Xiangxing Ma
Journal:  Quant Imaging Med Surg       Date:  2019-06

4.  Image-guided video assisted thoracoscopic surgery (iVATS) - phase I-II clinical trial.

Authors:  Ritu R Gill; Yifan Zheng; Julianne S Barlow; Jagadeesan Jayender; Erin E Girard; Philip M Hartigan; Lucian R Chirieac; Carol J Belle-King; Kristen Murray; Christopher Sears; Jon O Wee; Michael T Jaklitsch; Yolonda L Colson; Raphael Bueno
Journal:  J Surg Oncol       Date:  2015-05-28       Impact factor: 3.454

5.  Size of Non-lepidic Invasive Pattern Predicts Recurrence in Pulmonary Mucinous Adenocarcinoma: Morphologic Analysis of 188 Resected Cases with Reappraisal of Invasion Criteria.

Authors:  Soohyun Hwang; Joungho Han; Misun Choi; Myung-Ju Ahn; Yong Soo Choi
Journal:  J Pathol Transl Med       Date:  2016-10-16

Review 6.  Rationale for Lung Adenocarcinoma Prevention and Drug Development Based on Molecular Biology During Carcinogenesis.

Authors:  Hongming Zhang; Liting Guo; Jibei Chen
Journal:  Onco Targets Ther       Date:  2020-04-14       Impact factor: 4.147

7.  Correlation between high-resolution computed tomography lung nodule characteristics and EGFR mutation in lung adenocarcinomas.

Authors:  Yunqiang Nie; Hongjun Liu; Xiao Tan; Hui Wang; Fuzhou Li; Cuiyun Li; Ping Han; Xin Lyv; Xinyi Xu; Miao Guo
Journal:  Onco Targets Ther       Date:  2019-01-10       Impact factor: 4.147

8.  Evaluation of dynamic image progression of minimally invasive and preinvasive lung adenocarcinomas.

Authors:  Tianxiang Chen; Xiaocheng Zhang; Alessio Campisi; Angelo Paolo Ciarrocchi; Andrea Dell'Amore; Liwei Song; Yunhai Yang; Chengshui Chen; Qingquan Luo
Journal:  Ann Transl Med       Date:  2021-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.